Funding
← Back to your selection

Menlo Ventures

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026

Menlo Ventures backs early-stage technology companies, with a major focus on AI infrastructure and applications across enterprise, healthcare and consumer markets.

Its stated investment areas also include cybersecurity, fintech, robotics, hardware and supply-chain automation. Across these areas, Menlo examines how AI changes both the underlying infrastructure and the products businesses or consumers use.

The Menlo Anthology Fund is a $100 million initiative developed with Anthropic to finance AI startups. Menlo also publishes research on enterprise, consumer and healthcare AI adoption, offering founders evidence about buyer demand and spending in their markets.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$615M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series C+1

By primary sector

Biotech2

By country

United States2

Rounds

2 in this selection
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A
Participant
Chai Discovery

Building AI models to accelerate pre-clinical drug discovery

$400MSeries C
Role not disclosed